We are monitoring the impact of COVID-19 on Latin America Aptamers Market Get in touch with us for detailed analysis Know More
Share on

Latin America Aptamers Market Research Report - Segmented By Type, Application, End User, & Country (Mexico, Brazil, Argentina, Chile & Rest of Latin America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1075
Pages: 145

Latin America Aptamers Market Size (2022 to 2027)

The Latin American Aptamers Market size is expected to be growing at a CAGR of 17.5% from 2022 to 2027. As a result, the size of the market is predicted to value USD 25.03 million in 2022 and USD 56.05 million by the end of 2027.

The increasing life-threatening diseases like cancer, cardiovascular diseases, and AIDS majorly drive the demand for effective assays based on Aptamer therapy. Also, the growing R&D Savings in the pharmaceutical and biotechnology industries and technological advancements in the healthcare sectors contribute to market growth in this region. Furthermore, the patent expiry of the systematic development of ligands by exponential improvement technology and the low price and high productivity of aptamers in binding to giant molecules as linked to antibodies are predicted to propel the market ahead.

As time efficiency is so important in the healthcare sector, many research institutions invest in developing cost- and time-effective selection techniques. But, on the other hand, the growing applications of aptamers in the food and chemicals industries are projected to provide lucrative growth opportunities for market growth.

Owing to their great flexibility, they bind to highly selective and precise molecules, such as proteins, peptides, and carbohydrates. As a result, aptamers are now being utilized to diagnose various illnesses and detect tiny compounds. In addition, aptamers can be utilized as functional proteomic levels and pharmaceutical lead section reagents. Moreover, the various benefits that these small molecules provide over known antibodies have led to increased demand for these molecules in various medicinal applications.

However, a shortage of skilled professionals may impede market expansion throughout the forecast period. Also, the producers have opted to avoid using these compounds due to a lack of expertise and technological expertise concerning aptamers.

This research report has been segmented and sub-segmented the Latin American Aptamers Market into the following categories:

By Type: 

  • Peptide aptamers
  • Nucleic Acid aptamers
    • DNA-Based Aptamers
    • RNA-Based Aptamers
    • XNA-Based Aptamers

By Application: 

  • Therapeutics Development
  • Diagnostics
  • Research and Development

By End User: 

  • Pharmaceutical Companies
  • Bio-Pharmaceutical companies
  • Academic and Research Centres

By Country: 

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

The Latin American Aptamers market is projected to witness a considerable share in the global market during the forecast period. Continuous advancements in selection techniques remain a critical lever to the growth of the aptamer market. Also, the key market players are favorable government policies, acceleration in the investments in Research and Development activities, and Rising R&D investments in biotechnology and pharmaceutical industries. The major companies in the region are implementing various strategies to gain a competitive advantage over the competitors. The strategies include collaborations and mergers between research labs and academic institutions to offer next-generation products and enhance their market presence. In addition, developing countries such as Brazil and Mexico are expanding the Latin American market growth.

The Brazilian aptamers market is anticipated to account for the largest share of the Aptamer market in Latin America. The market growth is projected to be fuelled by increasing R&D expenditure, availability of advancing technology, and growing demand for these molecules.  However, the most important aspect in treating diseases, particularly viral infections, is an accurate diagnosis. As a result, aptamer technology has seen a considerable increase in demand and utilization throughout Latin America during the last few years. It's been utilized in various diagnostic and therapeutic purposes, and numerous techniques involving aptamers against viral proteins are presently being investigated, definitely or conclusively.

Similarly, the Mexican Aptamers market is projected to witness a moderate share during the forecast period. Growing usage of aptamers is quite common in all the fields; increasing research and development activities and rising government expenditure to support the R&D activities are augmenting the market growth.

KEY MARKET PLAYERS:

Companies playing a noteworthy role in the Latin America aptamers market are AM Biotechnologies, Aptagen, Aptamer Sciences Inc., Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., SomaLogic Inc, TriLink BioTechnologies Inc., and Vivonics, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Peptide Aptamers

                                5.1.2 Nucleic Acid Aptamers       

                                                5.1.2.1 DNA-Based Aptamers

                                                5.1.2.2 RNA-Based Aptamers

                                                5.1.2.3 XNA-Based Aptamers

                5.2 By Application                           

                                5.2.1 Therapeutics Development             

                                5.2.2 Diagnostics             

                                5.2.3 Research and Developments          

                5.3 By End Users                             

                                5.3.1 Pharmaceutical Companies             

                                5.3.2 Bio-Pharmaceutical Companies     

                                5.3.3 Academic and Research Centers    

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 Brazil             

                                6.3 Mexico         

                                6.4 Rest of Latin America             

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 AM Biotechnologies               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Aptagen                      

                8.3 Aptamer Sciences Inc.                            

                8.4 Aptamer Solutions Ltd                           

                8.5 Aptus Biotech S.L.                    

                8.6 Base Pair Biotechnologies Inc                             

                8.7 NeoVentures Biotechnology Inc.                       

                8.8 SomaLogic Inc                           

                8.9 TriLink BioTechnologies Inc                  

                8.10 Vivonics, Inc                            

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Latin America Aptamers Market, By Type, From 2022 - 2027 (USD Million)
  2. Latin America Peptide Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  3. Latin America Nucleic Acid Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  4. Latin America Aptamers Market, By Application, From 2022 - 2027 (USD Million)
  5. Latin America Therapeutics Development Market, By Region, From 2022 - 2027 (USD Million)
  6. Latin America Diagnostics Market, By Region, From 2022 - 2027 (USD Million)
  7. Latin America Research and Development Market, By Region, From 2022 - 2027 (USD Million)
  8. Latin America Aptamers Market, By End users, From 2022 - 2027 (USD Million)
  9. Latin America Pharmaceutical Companies Market, By Region, From 2022 - 2027 (USD Million)
  10. Latin America Bio-Pharmaceutical Companies Market, By Region, From 2022 - 2027 (USD Million)
  11. Latin America Academic and Research centres Market, By Region, From 2022 - 2027 (USD Million)
  12. Brazil Aptamers Market, By Type, From 2022 - 2027 (USD Million)
  13. Brazil Aptamers Market, By Application, From 2022 - 2027 (USD Million)
  14. Brazil Aptamers Market, By End users, From 2022 - 2027 (USD Million)
  15. Rest of Latin America Aptamers Market, By Type, From 2022 - 2027 (USD Million)
  16. Rest of Latin America Aptamers Market, By Application, From 2022 - 2027 (USD Million)
  17. Rest of Latin America Aptamers Market, By End users, From 2022 - 2027 (USD Million)
  18. Latin America Aptamers Market, By Nucleic Acid Aptamers, From 2022 - 2027 (USD Million)
  19. Latin America DNA Based Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  20. Latin America RNA Based Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  21. Latin America XNA Based Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  22. Brazil Aptamers Market, By Nucleic Acid Aptamers, From 2022 - 2027 (USD Million)
  23. Rest of Latin America Aptamers Market, By Nucleic Acid Aptamers, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample